Virax Biolabs Group Limited Ordinary Shares

Quarterly Financials

Values in thousands 2024-09-30 2024-06-30
Revenue
$4
$79
Gross Profit
-6
40
EBITDA
-2,766
-3,722
EBIT
-2,878
-3,808
Net Income
-2,756
-3,823
Net Change In Cash
4
79
Free Cash Flow
-2,166
-3,249
Cash
7,285
3,589
Basic Shares
3,103
2,237

Annual Financials

Values in thousands 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Revenue
$6
$156
$8
$0
Gross Profit
-53
50
-1
0
EBITDA
-5,802
-6,609
-5,442
EBIT
-6,145
-6,712
-5,442
-1,734
Net Income
-6,061
-6,733
-5,457
-1,708
Net Change In Cash
6
156
8
0
Free Cash Flow
-5,167
-7,411
-4,358
-809
Cash
4,228
3,589
9,352
21
Basic Shares
3,103
2,006
1,062
1,137

Earnings Calls

Quarter EPS
2025-06-30
-$0.76
2024-09-30
-$0.89
2022-06-30
-$0.03